NCT06202976 · ClinicalTrials.gov record · last posted 2025-04-17
Mapping Epileptic Networks Using Multimodal Imaging
Study acronym: CREIM
StatusRecruiting
PhaseNot specified
Started2017-09-14
View on ClinicalTrials.gov ↗
from the ClinicalTrials.gov record
Currently, mapping the epileptogenic zone is based on a comprehensive preoperative assessment involving clinical, imaging and electrophysiological examinations.
To reduce the need for invasive stereoelectroencephalography (SEEG) explorations, electrophysiological and imaging methods have been developed, such as resting-state functional MRI (fMRI) coupled with electroencephalogram and arterial spin-labeling perfusion MRI (ASL-MRI).
It has been published that these new methods enable precise delineation of the epileptogenic zone and better preparation for surgery.
The aim is to determine whether, in children with focal lesional epilepsy, the combination of ASL-MRI-EEG and resting-state fMRI-EEG enables precise identification of the epileptogenic zone to be defined by SEEG, the current reference examination.
Amendment record
1 amendment on the ClinicalTrials.gov record
This ClinicalTrials.gov record has been amended once since 2024-01-02. DataLookout shows field-level changes from the day a trial enters its daily monitoring; earlier amendments are counted here from the ClinicalTrials.gov version history.
See every version on ClinicalTrials.gov ↗
| NCT Number |
NCT06202976 |
| Lead Sponsor |
Imagine Institute
|
| Conditions |
Epilepsy in Children |
| Enrollment |
75 participants |
| Start Date |
2017-09-14 |
| Primary Completion |
2033-09-13 (estimated) |
| Study Completion |
2033-09-13 (estimated) |
| Updated on ClinicalTrials.gov |
2025-04-17 |